Table 4.
Adjusted odds ratios (OR) and 95% confidence intervals (CI) of the presence of hyperuricemia associated with the visceral adiposity index, along with metabolic health and obesity phenotypes defined by ATP-III and HOMA criteria, respectively.
| Model 1 | ATP-III criteria | HOMA criteria | |||
|---|---|---|---|---|---|
| Model 2 | Model 3 | Model 2 | Model 3 | ||
| Visceral adiposity index | |||||
| 1st Quartile | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
| 2nd Quartile | 1.41 (1.16–1.73) | 1.36 (1.11–1.66) | 1.3 (1.06–1.59) | 1.36 (1.11–1.66) | 1.29 (1.06–1.58) |
| 3rd Quartile | 2.29 (1.90–2.76) | 1.95 (1.60–2.38) | 1.77 (1.45–2.17) | 2.03 (1.67–2.46) | 1.85 (1.52–2.24) |
| 4th Quartile | 6.93 (5.79–8.29) | 4.88 (3.92–6.09) | 4.38 (3.49–5.49) | 5.65 (4.68–6.82) | 5.07 (4.18–6.14) |
| Obesity phenotype | |||||
| MHNO | — | 1 (Ref) | 1 (Ref) | 1 (Ref) | 1 (Ref) |
| MUNO | 1.29 (1.08–1.54) | 1.27 (1.05–1.54) | 1.44 (1.20–1.72) | 1.54 (1.27–1.87) | |
| MHO | 1.19 (0.96–1.48) | 1.11 (0.89–1.38) | 1.25 (1.06–1.47) | 1.16 (0.98–1.38) | |
| MUO | 1.93 (1.59–2.35) | 1.78 (1.43–2.20) | 2.16 (1.79–2.60) | 2.07 (1.69–2.53) | |
Abbreviations: ATP-III, the Adult Treatment Panel-III; HOMA, homeostasis model assessment of insulin resistance; MHNO, metabolically healthy non-obese; MUNO, metabolically unhealthy non-obese; MHO, metabolically healthy obese; and MUO, metabolically unhealthy obese. Model 1: Adjusted for age and sex. Model 2: Adjusted for Model 1 + urban/rural resident, smoking status, alcohol status and metabolic health-obesity phenotypes. Model 3: Adjusted for Model 2 + white blood cell, total cholesterol, blood pressure, glucose and hs-CR.